Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3767355019 | Product containing certolizumab pegol in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3767356018 | Certolizumab pegol-containing product in parenteral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing certolizumab pegol in parenteral dose form (medicinal product form) | Is a | Product manufactured as parenteral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing certolizumab pegol in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing certolizumab pegol in parenteral dose form (medicinal product form) | Is a | Product containing certolizumab pegol | true | Inferred relationship | Existential restriction modifier | ||
| Product containing certolizumab pegol in parenteral dose form (medicinal product form) | Has active ingredient | Certolizumab pegol | true | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only certolizumab pegol in parenteral dose form (medicinal product form) | Is a | True | Product containing certolizumab pegol in parenteral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR